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It has now been 50 years—10 years before the first
landing on the moon—that Cornfield and colleagues1
tried to put to rest the discussion and arguments
questioning the role of cigarette smoking in the
aetiology of lung cancer. In a 40-page article in
the Journal of the National Cancer Institute, several of
the leading figures in the USA of the developing
discipline called ‘chronic disease epidemiology’ sum-
marized the current state of knowledge that impli-
cated cigarette smoking as the leading factor
contributing to the development of lung cancer. This
review article did not adhere to current standards
for a systematic review. It is nevertheless remarkable
in many ways. It reviewed not only the epidemiologi-
cal evidence ranging from descriptive to analytical
epidemiology, but also included studies of carcinogen-
esis in laboratory animals. It examined, one by one,
the arguments against the cigarette–lung cancer
hypothesis.
A group of epidemiology students in Bern recently
discussed this article as part of their training. They
were surprised that half a century ago epidemiologists
clearly recognized the various possible biases inherent
in descriptive and observational epidemiology and the
difficulties in interpreting such evidence. Those
arguing against the cigarette–lung cancer hypothesis
used several lines of argument.
 Descriptive epidemiology—showing dramatic
increases in lung cancer incidence and mortality
in the first half of the 20th century—provides an
incorrect picture due to time trends in diagnostic
accuracy, better recording and changes in the age
structure of the populations in the USA and Europe.
 Case–control studies are plagued by selection and
information bias, resulting in risk associations that
may be spurious.
 Prospective studies can be flawed in ways that also
produce spurious associations.
 The majority of smokers do not develop lung
cancer, thus refuting a simplistic all-or-none mech-
anism of disease development.
 Results from animal studies are inconsistent.
 There may be an unmeasured characteristic ‘X’ that
is the real cause of lung cancer but associated with
becoming a smoker, thus producing a spurious
smoking–lung cancer association.
 In the absence of evidence from controlled experi-
ments in humans, confounding by such a factor ‘X’
cannot be ruled out.
In taking up these arguments, Cornfield and collea-
gues implicitly worked through a ‘check list’ to judge
causality of risk factor–disease associations, which is
reminiscent of the list put forward by Sir Austin
Bradford Hill2 in 1965, 6 years later. This seems
to confirm a rule that for anything named after a
person, there is someone else who had said or done
it before (fortunately, I cannot remember to whom
this rule should be accredited). Cornfield and collea-
gues, predating Hill, stressed that it is important to
see a coherent pattern in population-based incidence
rates, consistent findings across populations and
study designs and a strong association on the relative
risk scale, with a robust dose–response pattern.
Cornfield and colleagues could not truly refute all
of the counter arguments. However, they organized
their arguments with something we nowadays
would recognize as the Bayes factor.3,4 For each
dimension of evidence, the likelihood ratio was infor-
mally discussed in which the likelihood of the data
under the cigarette–lung cancer hypothesis was com-
pared with the likelihood of the data under the alter-
native hypothesis. This approach was particularly
clear when Cornfield and colleagues dealt with the
criticism of Berkson, that the prospective studies on
smokers and non-smokers could have given biased
results because people who did not smoke were ‘bio-
logically self-protective’5: ‘in this event, during the
earlier period after selection, the death rate of
the smokers in the study would be higher than the
death rate of the non-smokers in the study, even if
death rates were unrelated to smoking habits in the
general population. If smoking is unrelated to death
from lung cancer (or other causes), the death rate of
the smokers would tend to equalize with that of the
non-smokers as the study progressed’.1 But this was
not what was observed, rather ‘the observed associa-
tion between cigarette smoking and lung cancer was
Institute of Social and Preventive Medicine (ISPM), University
of Bern, Bern, Switzerland. E-mail: zwahlen@ispm.unibe.ch
stronger in the latter part than in the early part of the
study’.1
For Cornfield and colleagues, the most difficult chal-
lenge was the argument implicating a confounding
variable ‘X’. Here, Cornfield and colleagues had to
combine arguments about the strength of the associ-
ation (a relative risk of about nine when comparing
smokers with non-smokers and one of a factor 60
when comparing heavy smokers with non-smokers),
and how strongly associated this factor ‘X’ would
need to be with smoking to produce these associa-
tions. As outlined in Appendix A of their article,
boundaries can be derived on how prevalent the
factor ‘X’ would need to be in smokers compared
with non-smokers. These boundaries were then used
to argue that no one could suggest a candidate for
such a characteristic ‘X’ and the odds of finding one
in the future seemed very small indeed. Here,
Cornfield and colleagues clearly illustrate why epide-
miologists examine relative risk measures when asses-
sing whether an observed association is likely to be
causal. Furthermore, we find here an early example
of explicitly and quantitatively accounting for an
unobserved additional variable. The area of explicitly
modelling bias mechanisms or the influence of unob-
served (often called latent) variables has gained
importance in epidemiology in recent years.6–8
In a Bayesian inference framework of continuous
learning from the available evidence,9 one revises the
prior odds of a hypothesis (compared with an alterna-
tive hypothesis) by multiplying it with the likelihood
ratio of the data under the two hypotheses under con-
sideration. When several independent sources of evi-
dence are available, one can multiply the respective
likelihood ratios to arrive at a final assessment,
taking into account the totality of the evidence. It is
hardly surprising that Jerome Cornfield (1912–79),
who has been described as one of the most influential
biostatisticians in the USA (with little formal training
and no degree in statistics),10 later contributed to the
theory of Bayesian inference.11–13
No single study or source of evidence was able to put
the debate on the association between cigarette smok-
ing and lung cancer at rest. But, as our PhD students
quickly realized, this seminal paper integrated the
totality of evidence to demonstrate that the cigarette–
lung cancer hypothesis was much more likely to be true
than any of the alternative hypotheses put forward by
the opponents. Of course, our students raised the ques-
tion when the evidence becomes compelling enough to
justify public health action. They were shocked when
realizing how slow society can be in taking action.
Cornfield and colleagues were well aware of the diffi-
culties of changing a widespread habit that was sup-
ported by a powerful industry: ‘. . . if the findings had
been made on a new agent, . . . and on one which did
not support a large industry, skilled in the arts of mass
persuasion, the evidence for the hazardous nature of
the agent would be generally regarded as beyond dis-
pute’.1 Switzerland is finally introducing smoking bans
in public places that are more or less stringent, depend-
ing on the Canton. In the Canton of Bern, the smoking
ban came into law on 1 July 2009, almost 50 years after
the Cornfield paper. But people can still light up in
some restaurants, which provide separate smoking
areas.
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